DCAF7 and neoplasm: In conclusion, this study positions DCAF7 as a multi‐layered oncogenic driver that integrates genetic, epigenetic and immune cues across cancers, with particularly strong evidence of Wnt‐mediated tumour‐promoting activity in hepatocellular carcinoma.